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Alternative pre-mRNA splicing has the potential to greatly diversify the repertoire of tran-
scripts in multicellular organisms. Increasing evidence suggests that this expansive layer
of gene regulation plays a particularly important role in the development and function of the
nervous system, one of the most complex organ systems found in nature. In this review,
we highlight recent studies that continue to emphasize the influence and contribution of
alternative splicing regulation to various aspects of neuronal development in addition to its
role in the mature nervous system.
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INTRODUCTION
The nervous system is a uniquely complex structure, composed
of diverse classes of neuronal cells found in close proximity to
one another. These many classes of neurons must form precise
synaptic connections with other neurons that can often be sepa-
rated by large distances, establishing the circuitry governing the
ability to sense, interpret, and appropriately respond to stimuli.
It is of great interest to understand how the developmental steps
of neurogenesis, migration, pathfinding, synapse formation, and
maintenance are controlled with such precision. Defects in any
of these processes in humans lead to numerous cognitive and
motor disabilities (Mitchell, 2011). It is also of importance to bet-
ter grasp the mechanisms governing the modulation of synaptic
strength and plasticity in the mature nervous system, which plays
a key role in sensory adaptation, learning and memory, and other
behaviors.
Diverse spatio-temporal gene regulatory mechanisms have
proven vital for the control of patterning in the nervous system,
including regulation of mRNA synthesis by transcription factors
(West and Greenberg, 2011), the dynamic alteration of chromatin
states through modifying enzymes (Ooi and Wood, 2008; Yoo
et al., 2009), turnover or translational repression by microRNAs
(Meza-Sosa et al., 2012), RNA decay pathways, and regulation by
post-translational modifications (Fukushima et al., 2009). Alter-
native splicing, the process in which multiple mRNA isoforms can
be generated through differential splice site selection in precursor
transcripts, is an additional important mechanism of gene reg-
ulation, contributing to transcriptomic and proteomic diversity
in metazoans (Nilsen and Graveley, 2010). Greater than 95% of
human genes undergo alternative splicing (Pan et al., 2008; Wang
et al., 2008), and disruption of splicing contributes to a number of
genetic diseases (Chakarova et al., 2002; Briese et al., 2005; Win-
kler et al., 2005; Mordes et al., 2006; Wang and Cooper, 2007).
The nervous system exhibits particularly high levels of alternative
splicing (Yeo et al., 2004; Grosso et al., 2008). Indeed, a recent large
scale study of human tissues found that the cerebellum exhibited
the highest degree of alternative splicing among 11 tested tissue
samples, containing 50% more differentially expressed alternative
exons than the next highest tissue (the testes; de la Grange et al.,
2010). These results suggest that regulated splicing can serve as a
potential mechanism for generating the high levels of molecular
and cellular diversity observed in the nervous system (Lipscombe,
2005; Li et al., 2007).
The fidelity and efficiency of splicing depends on the action
of five small nuclear RNAs (snRNAs) functioning as components
of ribonucleoprotein particles called snRNPs, in conjunction with
up to hundreds of additional auxiliary proteins (Wahl et al., 2009).
This elaborate and highly dynamic complex known as the spliceo-
some regulates splicing with single nucleotide precision (Will and
Luhrmann, 2011). Decades of research have begun to elucidate
the “splicing code,” the complete set of cis-acting RNA features
(for example, sequence motifs, exon and intron length, secondary
structure) and trans-acting splicing factors that dictate where
and in what context differential splicing will occur in transcripts
(Wang and Burge, 2008; Barash et al., 2010). The combination
of detailed biochemical experiments with more recent genome-
wide approaches and computational analyses have revealed diverse
mechanisms by which alternative splicing can occur, and have
been described in greater detail in several recent excellent reviews
(Blencowe, 2006; Chen and Manley, 2009; Licatalosi and Darnell,
2010; Han et al., 2011; McManus and Graveley, 2011; Irimia and
Blencowe, 2012).
In this focused review, we examine the role of alternative splic-
ing during neuronal development and in response to neuronal
activity. Although a large number of alternative isoforms derived
from important neuronal genes have been reported in the litera-
ture, special emphasis is given here to recent findings illuminating
the role of specific trans-acting splicing factors and select target
splicing events they regulate in the biogenesis and function of
neurons.
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ALTERNATIVE SPLICING IN NEURONAL DEVELOPMENT AND
MAINTENANCE
Alternative splicing plays an important role in generating diversity
and specificity in the developing and mature nervous system. In
this section we describe several recent examples demonstrating the
role of alternative splicing in neuronal differentiation, migration
and pathfinding, and synapse formation and function (Figure 1).
THE RS DOMAIN-CONTAINING SPLICING FACTOR nSR100/SRRM4
CONTROLS NEUROGENESIS
The neural-specific SR-related protein of 100 kDa (nSR100/SRRM4)
was identified in a computational and expression based survey of
genes encoding RS domain-containing proteins (Calarco et al.,
2009). In a similar manner as other members of the SR and SR-
related family of proteins, nSR100 was found to regulate alternative
splicing decisions. Microarray profiling experiments in mouse
neuroblastoma cells and tissues revealed that depletion of nSR100
results in increased skipping of alternatively spliced exons nor-
mally included in the brain, suggesting that it mainly acts to
promote the inclusion of alternative exons. A significant frac-
tion of genes containing these regulated exons are known to be
important for regulating neuronal differentiation, raising the pos-
sibility that specific splice variants modulated by nSR100 could
contribute to this process. Consistent with this notion, nSR100 was
found to play a critical role in neuronal differentiation and neurite
extension in vitro as well as nervous system and sensory organ
development in zebrafish embryos in vivo (Calarco et al., 2009).
The specific mechanism by which nSR100 regulates alternative
splicing in the nervous system remains to be elucidated. However,
nSR100 was shown to be required for proper inclusion of a tar-
get neural-specific exon using in vitro splicing extracts, indicating
that it plays a direct biochemical role in promoting exon inclusion
(Calarco et al., 2009). It was also found that the introns flanking
alternative exons regulated by nSR100 are enriched in pyrimidine
rich motifs (Calarco et al., 2009). The majority of these motifs
are likely recognized by the polypyrimidine tract binding protein
PTBP1 and its tissue-specific paralog PTBP2 (also called neural-
or brain-enriched n/brPTB). Consistent with a link between these
regulators in modulating neural-specific alternative splicing, many
nSR100-dependent alternative splicing events are also regulated by
PTBP1 and PTBP2.
More recently, it was discovered that nSR100 indirectly controls
the steady-state abundance of a network of transcripts in neuronal
cells distinct from the population of mRNAs that it regulates at
the level of splicing. Depletion of nSR100 in mouse neuroblas-
toma cells led to decreased levels of hundreds of transcripts, and
a subset of these changes were shown to be dependent on repres-
sor element 1 silencing transcription factor (REST, also known as
NRSF), a transcriptional repressor of genes involved in neurogen-
esis (Raj et al., 2011). In neuronal cells, REST transcripts include
an additional exon that results in the introduction of a stop codon
and production of a truncated protein lacking domains required
for its repressive activity. Raj et al. (2011) found that nSR100 plays
a critical role in promoting the inclusion of this alternative exon,
suggesting that the expression of nSR100 in neurons contributes to
the reduced activity of REST upon differentiation to the neural lin-
eage. Importantly however, REST was also found to directly repress
nSR100 transcription in non-neuronal cells and thus indirectly
inhibit neural-specific alternative splicing. This negative feedback
loop between two gene regulatory levels was found to be important
for developmental outcomes in the nervous system, as inhibiting
nSR100 expression in mouse brain disrupted cortical neuroge-
nesis, preventing neuronal precursor cells from committing to a
neuronal fate (Raj et al., 2011). These results are in agreement with
FIGURE 1 | Notable alternative splicing events important for nervous
system development, and the factors implicated in regulating their
splicing patterns. Developmental stages are represented by the arrow,
beginning with neurogenesis, and ending with synapse maturation and
function. Splicing factors and target transcripts are correspondingly color
coded to the developmental stage in which they are known to be important.
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previous studies showing that loss of REST de-represses neuronal
transcripts in non-neuronal tissues, while REST overexpression
inhibits the expression of transcripts in neuronal tissues, which in
one study was shown to result in axon pathfinding errors in chick
embryos (Chen et al., 1998; Paquette et al., 2000).
THE SPLICING FACTOR NOVA-2 CONTROLS NEURONAL MIGRATION
The Nova RNA binding proteins were among the first tissue-
specific regulators of alternative splicing to be identified. Initial
studies in knockout mice indicated that Nova-1 plays a critical
role in the maintenance of brainstem and spinal cord neurons,
likely through the regulation of alternative splicing in these cells
(Jensen et al., 2000). Subsequent studies utilizing splicing-sensitive
microarray profiling in mice lacking Nova proteins identified a net-
work of brain-specific splicing events coordinated by these factors
(Ule et al., 2005). Importantly, transcripts with Nova-regulated
exons encoded proteins that were significantly enriched in func-
tions associated with the synapse (Ule et al., 2005). Integrating
this alternative splicing regulatory network with genome-wide
cross-linking and immunoprecipitation (CLIP; Licatalosi et al.,
2008; Zhang et al., 2010) studies identifying in vivo Nova binding
sites in the transcriptome has provided two key advances. First,
these datasets have enabled the formulation of “RNA maps” cor-
relating cognate Nova YCAY cis-element locations in pre-mRNA
transcripts with effects on splicing regulation, leading to mech-
anistic insights into how the Nova proteins modulate alternative
splicing (Ule et al., 2006). Second, these networks identify target
isoforms and pathways that likely contribute to aspects of neuronal
physiology. In agreement with this latter point, subsequent pheno-
typic exploration of the role of target isoforms in Nova knockout
mice has identified a role for Nova in modulating slow synap-
tic inhibition and in neuromuscular junction formation (Huang
et al., 2005; Ule et al., 2005; Ruggiu et al., 2009).
Recently, Nova-2 was demonstrated to be important for the
migration of late-born cortical and Purkinje neurons in mice
(Yano et al., 2010). These migration defects were due largely to
the aberrant splicing of transcripts from a single gene, the Reelin
signaling adaptor Disabled-1. Reelin signaling is an important
pathway regulating neuronal migration in the cortex, cerebellum,
and hippocampus. Binding of the Reelin ligand to its recep-
tors ApoER2 and Vldlr leads to phosphorylation of Disabled-1,
which recruits various adaptor proteins that mediate cytoskeletal
rearrangements and appropriate neuronal migration and posi-
tioning (Bar et al., 2000; Ayala et al., 2007). Disabled-1 is thus a
critical effector protein in the Reelin signaling pathway.
Nova-2 suppresses the inclusion of Disabled-1 exons 7b and
7c (7bc+), which encode an additional 33 amino acid peptide of
unknown function, the inclusion of which could produce a protein
isoform with dominant negative activity. Expression of Disabled-
1 (7bc+) in the E14.5 mouse cortex was sufficient to cause
migration defects similar to the Nova-2 knockout, while Disabled-
1 (7bc−) substantially rescued the Nova-2 knockout migration
defects (Yano et al., 2010). Thus, Nova-2 controls the sensitivity of
neurons to the Reelin signaling pathway, presumably by affecting
the balance of Disabled-1 (7bc−), which is activated by the Reelin
signaling pathway, and Disabled-1 (7bc+), which, through a cur-
rently unknown mechanism, impairs the Reelin signaling pathway.
The alternative splicing of Disabled-1 is developmentally regu-
lated, with Nova2-dependent suppression of Disabled-1 (7bc+)
highest during the critical window of migration for late-born
neurons (E14.5–E16.5), suggesting Nova2-mediated alternative
splicing of Disabled-1 as a mechanism to control neuronal sen-
sitivity to Reelin signaling throughout development (Yano et al.,
2010).
PTBP1 AND PTBP2 REGULATE SYNAPSE FORMATION AND
MAINTENANCE
PTBP1 and PTBP2 display mutually exclusive patterns of expres-
sion in the developing brain, with PTBP1 found in glial and
non-neuronal cells, and PTBP2 in neurons (Boutz et al., 2007).
This non-overlapping pattern of expression is established by an
elegant cross-regulatory network where PTBP1 normally sup-
presses the inclusion of an exon in PTBP2 transcripts, leading
to a non-functional isoform degraded by the nonsense-mediated
mRNA decay (NMD) pathway (Boutz et al., 2007; Spellman et al.,
2007). In neurons however, PTBP1 is silenced by miR-124, a
neuron-specific microRNA, leading to the de-repression of PTBP2
(Makeyev et al., 2007). The consequences of modulating the rel-
ative levels of PTBP1 and PTBP2 in neuronal cells have been
initially revealed through splicing-sensitive microarray profiling
of mouse neuroblastoma cells depleted of these factors (Boutz
et al., 2007). Analogous to the Nova-regulated alternative splic-
ing network, PTBP1- and PTBP2-dependent alternative splicing
events are frequently found in transcripts expressed from genes
with known roles in neuronal differentiation and physiology.
A role for PTBP1 and PTBP2 in regulating the expression of
PSD-95, an important scaffolding protein essential for synap-
tic maturation and plasticity of excitatory neurons, has recently
been identified. Overexpression of PTBP1 and PTBP2 in cultured
hippocampal neurons was shown to repress synaptic activity, den-
dritic spine formation, and reduce levels of PSD-95 transcripts
(Zheng et al., 2012). This reduced mRNA abundance is caused
by PTBP1 and PTBP2 binding to a pyrimidine rich cis-element
upstream of PSD-95 exon 18, leading to increased exon skipping
and the production of a transcript containing a premature ter-
mination codon that is targeted for degradation by the NMD
pathway. Importantly, the increased expression of PSD-95 in devel-
oping neurons in the cortex was found to correlate with three
distinct phases of PTBP1 and PTBP2 expression. At the neural
progenitor stage, when PTBP1 levels are high, PSD-95 expression
is at its lowest. In embryonic neurons, the weaker repressor PTBP2
is more highly expressed while PTBP1 expression is lost, leading to
intermediate levels of PSD-95. Finally, in post-natal cortical neu-
rons, PTBP2 is no longer expressed, allowing PSD-95 abundance
to reach its highest levels (Zheng et al., 2012). These results indi-
cate that the sequential changes in relative expression of PTBP1
and PTBP2 can allow for distinct splicing regulatory programs to
be established at different stages in neuronal maturation.
ALTERNATIVE SPLICING OF NEUREXINS AND NEUROLIGINS IN
SYNAPSE FORMATION AND MAINTENANCE
A number of studies in recent years have demonstrated the
importance of alternative splicing of neurexins and their binding
partners neuroligins in establishing and/or maintaining synapses
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(Boucard et al., 2005; Chih et al., 2006; Graf et al., 2006). Neurexins
and neuroligins function as adhesion proteins across the synap-
tic cleft, and increasing evidence suggest that these factors are
central organizing proteins at both glutamatergic and GABAer-
gic synapses in the brain (Craig and Kang, 2007). The Neurexin
gene loci are highly complex, with the capacity of generating thou-
sands of potential transcript variants pre-synaptically in mammals
through the use of alternative promoters and alternative splicing
(Boucard et al., 2005; Chih et al., 2006). The post-synaptic neuroli-
gins also undergo alternative splicing, but to a lesser degree. Several
key variants from each of these factors have been functionally char-
acterized in cell culture, leading to the proposal of a trans-synaptic
adhesive splicing “code” in which particular neurexin isoforms
have specific affinity to particular neuroligin isoforms, and the
isoforms utilized in neurons affect the functional properties of the
synapse (Boucard et al., 2005; Chih et al., 2006; Graf et al., 2006).
For instance, the addition of an alternative exon (B+) to neuroligin
1 decreased its ability to recruit GABAergic synaptic components
but increased its glutamatergic synaptic recruitment. This change
in activity was due to the reduced binding of neuroligin 1 (B+) iso-
forms to neurexin variants with splice site #4 selected (SS4+; Chih
et al., 2006). Neuroligin (B+) bound neurexin (SS4−) strongly but
exhibited only weak binding with neurexin (SS4+), while neuroli-
gin (B−) had strong interaction with both neurexin (SS4+) and
(SS4−) isoforms. These results point toward a role of neurexin and
neuroligin alternative splicing in shaping the strength and class of
synapses (Chih et al., 2006).
Several factors involved in the splicing of neurexin transcripts
have been identified. The first was PTBP2, which was demon-
strated to suppress selection of SS4 in neurexin-2α (Resnick et al.,
2008). More recently it has been demonstrated that the KH domain
RNA binding protein SAM68 regulates selection of the SS4 in
neurexin 1 and neurexin 3, and that it does so in a neuronal
activity-dependent fashion (further discussed below; Iijima et al.,
2011).
Rbfox-1/A2BP1 AND Rbfox-2/Rbm9 PLAY A ROLE IN NEURONAL
DEVELOPMENT AND FUNCTION
Members of the Rbfox family of RNA binding proteins display
enriched or highly specific expression patterns in the neuromus-
cular system, and regulate alternative splicing decisions through
interactions with the highly conserved cis-element (U)GCAUG
(Underwood et al., 2005; Zhang et al., 2008; Zhou and Lou, 2008;
Sun et al., 2012). Focused biochemical studies and several genome-
wide analyses have demonstrated that the Rbfox proteins can
function as activators or repressors of splicing, depending on the
location of (U)GCAUG elements in target pre-mRNA transcripts
(Jin et al., 2003; Zhang et al., 2008; Zhou and Lou, 2008; Sun et al.,
2012). Together, these studies have begun to shed light on the rele-
vant networks of transcripts modulated by these factors, although
the role of the Rbfox proteins in nervous system development and
function in vivo has remained somewhat unclear.
Two recent studies from the Black laboratory using Rbfox
knockout mice have provided further insight toward the functional
importance of these proteins in the nervous system (Gehman
et al., 2011, 2012). Deletion of Rbfox1 specifically in the nervous
system of transgenic mice did not seem to have any effects on
neuronal development or morphology in the brain. However, loss
of Rbfox1 did lead to spontaneous seizures, increased sensitivity
to induced seizures, and increased excitability in neurons of the
dentate gyrus. Integration of splicing-sensitive microarray pro-
filing and CLIP-Seq datasets identified alternative splicing events
differentially regulated in the brains of Rbfox1−/− mice, several of
which were linked to genes known to be associated with epilepsy
and others with roles in synaptic function (Gehman et al., 2011).
In contrast to loss of Rbfox1 in the nervous system, deletion of
the gene encoding Rbfox2 in the nervous system led to pronounced
defects in cerebellar development. Rbfox2−/− animals have much
smaller cerebella than wild-type littermates, defects in Purkinje
cell migration and dendritic arborization, and reduction in the
migration and number of granule cells (Gehman et al., 2012).
Again, splicing-sensitive microarray profiling experiments were
performed, revealing alternative splicing events displaying signifi-
cant changes upon loss of Rbfox2. Genes with affected exons were
associated with neuronal development and function, and a subset
of Rbfox2-dependent alternative splicing events were also regu-
lated by Rbfox1, suggesting partial redundancy between the two
factors. In agreement with these data, double knockout mice dis-
played far more severe phenotypes than those observed in either
single knockout mutant (Gehman et al., 2012). Finally, in an
attempt to separate a possible role for both Rbfox proteins in the
mature nervous system from their collective role in development,
transgenic animals were generated that deleted these two factors
specifically in Purkinje cells. Intriguingly, these double knockout
mice possess no gross morphological or developmental abnormal-
ities, but display impaired motor skills and significant reductions
in spontaneous firing frequency of Purkinje cells, demonstrating
that the Rbfox proteins also play an important role in mature
neural circuitry in addition to their contribution to development
(Gehman et al., 2012).
NEURONAL ACTIVITY-DEPENDENT ALTERNATIVE SPLICING
REGULATION
DEPOLARIZATION CAUSES CHANGES IN SPLICING OF NEURONAL
TRANSCRIPTS
Calcium signaling has long been recognized to play an important
role in various cellular processes such as muscle contraction and
gene transcription, and in neurons it is critical for modulating
neuronal activity and for learning and memory (West et al., 2001).
Increasing evidence suggests that depolarization-induced calcium
influx can also regulate alternative splicing in neurons. One of the
early studies showing splicing differences in response to neuronal
depolarization utilized the cholinergic agonist pilocarpine admin-
istered to the brains of rats. Chronic induction of depolarization
with pilocarpine caused altered alternative splicing patterns in a
number of key neuronal transcripts in the rat hippocampus and
cortex, including tra2-beta, clathrin light chain B, NMDAR1, and
c-src (Daoud et al., 1999).
A number of further studies using chemical treatments to
induce or inhibit calcium signaling in neurons have revealed
additional calcium-dependent alternative splicing events. For
example, Ania-6, an RNA polymerase II-associated cyclin, exhib-
ited increased inclusion of intron 6 upon glutamate stimula-
tion, but decreased inclusion when stimulated by depolarizing
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concentrations of KCl. Increased intron inclusion leads to altered
protein localization such that the longer isoform is found in
nuclear speckles and is associated with hyperphosphorylated RNA
Pol II (Berke et al., 2001; Sgambato et al., 2003). In a separate
study, mature transcripts encoding SNAP25, a membrane-bound
component of the SNARE complex essential for synaptic vesicle
fusion, were found to include one of two mutually exclusive alter-
native exons (5a or 5b). Chronic depolarization of PC12 cells or
of cerebellar granule cells by exposure to elevated extracellular
K+ resulted in altered splicing in which the abundance of the 5b
isoform is increased (Hepp et al., 2001).
MODULATION OF NEURONAL ACTIVITY DURING CIRCADIAN RHYTHMS
Another potentially interesting physiological process that influ-
ences neuronal activity over sufficiently long timescales to involve
new gene synthesis and RNA processing lies in the regulation
of circadian rhythms. The connection between regulated splicing
and circadian rhythms in the nervous system has been supported
by a recent study using RNA-Seq in the Drosophila brain, which
identified numerous splicing events regulated in response to cir-
cadian time or period, including splicing of key circadian genes
(Hughes et al., 2012). Furthermore, Sanchez et al. (2010) iden-
tified the arginine methyl transferase PRMT5, which methylates
arginine residues in the spliceosomal Sm proteins, in a screen for
novel genes affecting circadian clock regulation in Arabidopsis.
Mutations in PRMT5 were found to affect both transcription and
alternative splicing of many transcripts, including several compo-
nents of the circadian clock (Sanchez et al., 2010). The authors
further demonstrated that a mutation in the Drosophila prmt5
ortholog causes aberrant circadian-dependent behavior as well as
altered mRNA splicing patterns. In both organisms, loss of PRMT5
led predominantly to increased intron retention. Taken together,
these findings suggest that PRMT5 directly methylates splicing
factors, though an alternative model in which PRMT5 leads to
epigenetic changes cannot be ruled out (Sanchez et al., 2010).
Continued exploration of the mechanisms controlling circadian
regulation of alternative splicing will undoubtedly reveal novel
insights.
MECHANISMS OF ACTIVITY-DEPENDENT ALTERNATIVE
SPLICING
Although key neuronal transcripts undergoing depolarization-
dependent alternative splicing have been discovered, our under-
standing of the mechanisms controlling this phenomenon is
still in its infancy. In the sections that follow, we will highlight
current progress in elucidating the role of cis-elements, chro-
matin states, and RNA binding protein modification as regulators
of activity-dependent splicing (see Figure 2 for an outline of
examples).
mRNA ELEMENTS NECESSARY FOR ACTIVITY-DEPENDENT SPLICING
Several cis-elements regulating alternative splicing changes in
response to neuronal depolarization have been identified. The BK
(Big Potassium) channel encoded by the Slo gene in mammals
is important for determining calcium and voltage sensitivity in
neurons. The STREX exon of Slo, which contributes to enhanced
neuronal sensitivity to Calcium when included in transcripts
(Saito et al., 1997; Xie and Black, 2001), undergoes increased exon
exclusion in response to KCl-mediated depolarization in cultured
cells (Xie and Black, 2001). This depolarization-dependent alter-
native splicing required the Ca2+/calmodulin-dependent protein
kinase CaMKIV. The cis-elements that conferred responsiveness to
CAMKIV signaling were identified, and came to be known as CaR-
REs (CaMKIV-responsive RNA elements; Xie and Black, 2001).
Since then, a number of additional depolarization-dependent
alternatively spliced transcripts have been shown to contain CaR-
REs and to be responsive to CaMKIV (Xie et al., 2005; Lee et al.,
2007). Candidate RNA binding proteins that act downstream
of CaMKIV signaling and bind to the CaRREs had remained
elusive until recent years, when the heterogeneous ribonucleo-
protein hnRNP L was identified to interact with CaRRE1 at the
FIGURE 2 | Mechanisms of depolarization-dependent alternative
splicing, including known trans-acting factors, the cis-elements with
which they interact, and a representative alternative splicing event
regulated by each specific pathway. Established mechanisms are shown
as solid arrows, while activities with unknown intermediates are shown
with dashed lines.
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upstream 3′ splice site of the STREX exon (Yu et al., 2009). Knock-
down of hnRNP L led to increased inclusion of the STREX exon
prior to depolarization. However, upon treatment with KCl, cells
with reduced hnRNP L levels had smaller STREX exon inclusion
changes relative to control cells, but still showed some response
to depolarization (Yu et al., 2009). These results suggest that
other factors in addition to hnRNP L play a role in the observed
depolarization-mediated effects. Indeed, a more recent study has
now demonstrated that hnRNP L-like (hnRNP LL) acts redun-
dantly with hnRNP L for the complete modulation of the STREX
exon in response to depolarization (Liu et al., 2012).
An additional cis-element involved in activity-dependent splic-
ing was uncovered in experiments demonstrating that K+-induced
alternative splicing of the CI cassette exon of the NMDA R1 recep-
tor relied on the presence of two exonic UAGG silencing motifs.
These motifs were previously identified as part of a multicom-
ponent regulatory code involving 5′ splice site proximal GGGG
elements in coordinating tissue-specific splicing regulation of the
CI exon (Han et al., 2005). Introduction of the UAGG silencing
motif into a constitutively spliced exon in an unrelated gene led to
an increase in exon skipping, and importantly, further increased
skipping in response to extracellular K+-induced depolarization
(An and Grabowski, 2007). Biochemical studies demonstrated that
the association of the heterogeneous nuclear ribonucleoprotein
hnRNP A1 with these UAGG motifs was increased in response
to cellular excitation (An and Grabowski, 2007). Although it is
currently unclear how this increased association is induced, these
results suggest that a signaling cascade must exist that connects
responses to depolarization at the plasma membrane and in the
cytoplasm with subsequent effects on activity in the nucleus. Inter-
estingly, hnRNP A1 has been demonstrated to alter its shuttling
state between the nucleus and cytoplasm in response to osmotic
shock (Allemand et al., 2005). It will be interesting to determine
whether depolarization leads to increased shuttling of hnRNP A1
to the nucleus, which would offer a possible explanation for the
elevated association with UAGG elements observed.
MODIFICATION OF CHROMATIN
Nucleosome positioning and chromatin modification have been
recognized as important factors in memory formation and con-
solidation (Guan et al., 2002; Levenson et al., 2004). More recently,
chromatin state and epigenetic marks, including post-translational
histone-tail modifications and DNA methylation, have been found
to play an important role in alternative splicing regulation (Hnil-
icova and Stanek, 2011; Luco and Misteli, 2011). Genome-wide
analyses have indicated that nucleosomes have increased occu-
pancy in exons compared to flanking intronic regions, and that
local enrichment of certain histone modifications can facili-
tate alternative exon inclusion (see below; Nahkuri et al., 2009;
Schwartz et al., 2009; Tilgner et al., 2009; Huff et al., 2010). Con-
versely, splicing has also been found to be important for the
establishment of histone H3 lysine 36 methylation in intron-
containing genes, suggesting a bi-directional communication (de
Almeida et al., 2011; Kim et al., 2011). Additionally, and not mutu-
ally exclusive with the influence of chromatin state, the rate of
RNA polymerase II (pol II) elongation during nascent transcript
synthesis has also been found to affect alternative splicing (de la
Mata et al., 2003). Two models have been proposed to possibly
account for how pol II elongation can regulate alternative splic-
ing. First, the recruitment model suggests that splicing factors can
directly associate with pol II, likely via the C-terminal domain
(CTD) of its largest subunit. These pol II-recruited splicing factors
would then be available to recognize cognate cis-elements found in
nascent pre-mRNA transcripts. Second, the kinetic model posits
that chromatin structure influences the local rate of pol II tran-
scription elongation, potentially exposing normally weak splice
sites for extended periods of time, thereby allowing them to be
more efficiently recognized by the spliceosome (Kornblihtt, 2007;
Munoz et al., 2010).
Several recent studies have reinforced the hypothesis that local
enrichment of distinct histone marks and DNA methylation sta-
tus at alternative exons and flanking sequences can modulate pol
II elongation rate and alternative splicing. First, Luco et al. (2010)
have demonstrated using chromatin-immunoprecipitation assays
that H3-K36me3 marks are enriched around a set of alterna-
tive splicing events regulated by PTBP1. The histone-tail binding
protein MRG15, which specifically recognizes H3-K36me3, was
also found to be in a physical complex with PTBP1, thus pro-
viding a link between histone modifications and the potential
recruitment of splicing factors (Luco et al., 2010). In a separate
study, Shukla et al. (2011) discovered that the DNA-binding pro-
tein CCCTC-binding factor (CTCF) can mediate local pausing
of pol II and inclusion of weak alternative exons. These authors
further revealed that the action of CTCF is inhibited by DNA
methylation at these regulated exons, suggesting a mechanistic
link between elongation rate, methylation, and CTCF binding in
modulating alternative splicing. Finally, Close et al. (2012) have
identified a novel polymerase-associated complex called DBIRD
that was found to promote exon skipping. Depletion of com-
ponents of the DBIRD complex was found to predominantly
increase pol II occupancy surrounding regulated exons, leading
to more inclusion. In a search for cis-elements associated with
these DBIRD-sensitive exons, the authors identified enrichment
of (A+T) rich sequences, which have been shown in previous
studies to act as pol II elongation pause sites in vitro (Close et al.,
2012).
An intriguing study has also implicated neuronal depolariza-
tion in the control of alternative splicing by affecting RNA Pol II
transcription kinetics. Exon 18 of Neural Cell Adhesion Molecule
(NCAM) transcripts undergoes developmentally regulated alter-
native splicing in which the exon-excluded isoform (NCAM140) is
abundant in neuronal precursors while the exon-included isoform
(NCAM180) is increasingly expressed throughout the process of
neuronal differentiation (Pollerberg et al., 1985, 1986; Cunning-
ham et al., 1987). Schor et al. (2009) demonstrated that NCAM
exon 18 skipping increased in response to neuronal depolarization
with KCl. This depolarization-mediated increase in exon skipping
was not dependent on CaMKIV (Schor et al., 2009), but instead
involved histone modification changes specifically in the vicinity
of exon 18. Depolarization led to an increase in histone H3-K9
acetylation and H3-K36 tri-methylation exclusively in the region
between exons 17 and 19, as well as a local increase in chromatin
relaxation and accessibility. Furthermore, exon 18 inclusion could
be artificially recapitulated by either using a mutant“slow”pol II or
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by applying the drug trichostatin which inhibits histone deacety-
lation. These results are consistent with a kinetic coupling model
in which depolarization leads to specific local histone modifica-
tions in the region of the alternative exon causing local chromatin
relaxation, in turn increasing the speed of pol II transit through
the exon and facilitating increased exon 18 exclusion (Schor et al.,
2009).
REGULATION OF RNA BINDING SPLICING FACTORS
The activity or levels of RNA binding proteins that regulate alterna-
tive splicing can be modified in response to neuronal activity. For
instance, phosphorylation of hnRNP L on serine 513 by CaMKIV
was found to play a crucial role in the differential regulation of
STREX exon inclusion upon treatment of cells with KCl (Liu et al.,
2012), providing a molecular link between signaling downstream
of the stimulus and subsequent effects on alternative splicing.
Two recent studies have implicated the RNA binding protein
Rbfox-1/A2BP1 as an important splicing factor mediating activity-
dependent alternative splicing (Lee et al., 2009; Amir-Zilberstein
et al., 2012). First, transcripts encoding Rbfox-1 itself were identi-
fied as a target of depolarization-dependent splicing in mouse cells,
where exon 19 was found to be excluded in response to depolar-
ization. Exclusion of exon 19 led to the accumulation of a Rbfox-1
protein isoform targeted to the nucleus, where it re-activated the
inclusion of target exons initially displaying more skipping upon
depolarization (Lee et al., 2009). Thus, Rbfox-1 lacking exon 19
counteracted the effects of depolarization-dependent exon exclu-
sion, suggesting a novel feedback-based mechanism for adapting
to chronic neuronal depolarization. A second study implicated
Rbfox-1 as an important downstream target of the hypothala-
mic transcription factor Orthopedia (Otp) in response to stress
(Amir-Zilberstein et al., 2012). Rbfox-1 was demonstrated to be a
transcriptional target of Otp, and Rbfox-1 transcript levels were
upregulated in response to stress in mice. Rbfox-1 in turn was
responsible for an increase in exon 14 inclusion in the pitu-
itary adenylate cyclase-activating peptide (PACAP) receptor PAC1.
Inclusion of PAC1 exon 14 led to a decrease in the levels of stress-
induced corticotropin-releasing hormone (CRH). These results
suggest that Rbfox-1-mediated inclusion of PAC1 exon 14 cre-
ates an isoform that helps terminate stress-induced transcription
of CRH. In agreement with this model, zebrafish injected with
morpholinos inhibiting PAC1 exon 14 inclusion exhibited abnor-
mal “anxiety like” behavior and sustained expression of CRH
transcription (Amir-Zilberstein et al., 2012).
Another recent study has provided insight into the mechanism
controlling depolarization-dependent splicing of the neurexin
SS4+ alternative isoform. As discussed above, alternative splicing
of SS4 can modulate the affinity of neurexins for their post-
synaptic ligands. Iijima et al. (2011) have now shown that SS4
selection can be suppressed in response to induced depolarization
by various methods in cultured mouse neurons. This suppres-
sion of exon inclusion is dependent on CaMKIV and results in
altered trans-synaptic signaling in response to depolarization.
The STAR family RNA binding protein SAM68 was shown to
be required for depolarization-dependent splicing of SS4, and to
bind directly to AU-rich response elements in the neurexin pre-
mRNA. Although SAM68 protein levels and localization were not
affected by depolarization, a serine residue within a consensus
CaMKIV recognition motif was found to be more highly phos-
phorylated following depolarization. These results suggest a model
where neuronal depolarization affects CaMKIV due to increased
intracellular calcium, leading to the phosphorylation of SAM68,
which then alters neurexin splicing. Interestingly, the neurexin
pre-mRNA does not contain recognizable CaRRE sequences, and
a number of transcripts containing CaRRE sequences were not
affected by loss of SAM68 (Iijima et al., 2011). Thus, it appears
that CamKIV-dependent alternative splicing regulation depends
on multiple downstream RNA binding proteins binding to distinct
cis-elements.
PERSPECTIVES AND FUTURE DIRECTIONS
Neuronal depolarization can affect the splicing of many transcripts
in the nervous system, but the mechanisms by which it does so
still remain largely unknown. A major future challenge will be to
identify the signaling cascades in addition to the CAMKIV path-
way linking cellular excitation to alternative splicing via changes
in the activity of splicing factors, chromatin state, and perhaps
additional mechanisms. Moreover, experiments thus far revealing
a role of depolarization in nervous system alternative splicing have
relied on in vitro cell culture models requiring chronic depolar-
ization for many hours to modulate the firing activity of neurons.
It will now be important to understand how chronic neuronal
depolarization affects alternative splicing regulation in vivo, and
what consequences the affected isoforms have on neuronal physi-
ology. Many depolarization-responsive alternative splicing events
that have been identified are found in transcripts encoding chan-
nel proteins, neurotransmitter receptors, and other modulators
of synaptic strength (Xie and Black, 2001; Lee et al., 2007; Iijima
et al., 2011). Phenomena such as synaptic gain control and home-
ostasis, where synapses can alter their sensitivity in response to
chronic hyper- or hypo-stimulation (Burrone and Murthy, 2003),
are thought to occur over the course of hours. This time-frame
overlaps well with the temporal dynamics of depolarization-
induced alternative splicing changes observed in vitro. While it
may be a technically challenging feat, genome-wide analyses of
splicing changes in organisms maintained under differing stim-
uli or behavioral paradigms inducing such synaptic gain control
or homeostatic maintenance would provide further insight into
the mechanisms and relevance of neuronal activity in regulating
alternative splicing in vivo.
The fact that the activity of master regulators of gene expres-
sion such as transcription factors can be modified by alternative
splicing has blurred the lines of how differentiation programs in
cell lineages are established (Gabut et al., 2011; Raj et al., 2011).
In a broader sense, these results raise an interesting implication,
namely, that regulation of alternative splicing events by RNA bind-
ing proteins can play a causal rather than simply consequential
role in developmental transitions and activity states of neurons.
Future experiments establishing the contribution of splicing and
other RNA binding regulators to the identity and fate of neuronal
lineages represents an important goal in basic research but also
in biomedical applications such as regenerative medicine. While a
handful of neuronal-specific splicing regulators have been discov-
ered, it is unlikely that the current repertoire of known factors is
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sufficient to account for the remarkable degree of splicing com-
plexity observed in the nervous system. Hundreds of RNA binding
proteins have been identified in metazoan genomes, and many of
them remain uncharacterized. As such, identification and charac-
terization of novel regulators of splicing will be important. Large
scale RNAi and/or cDNA overexpression studies in cell culture
models will be useful for identifying factors whose inhibition or
overexpression affect splicing in the nervous system. Importantly,
invertebrate model organisms provide a valuable platform for per-
forming forward and reverse genetic screens to identify previously
uncharacterized factors affecting splicing. In addition to identify-
ing RNA binding proteins, such unbiased screens may also uncover
novel classes of genes not previously known to regulate alterna-
tive splicing, such as non-coding RNAs and chromatin regulators
(Luco et al., 2010; Tripathi et al., 2010). Furthermore, it will be
important to understand splicing regulation in the nervous system
in a more spatially resolved manner, for example, by identifying
brain sub-region and neuronal-subtype specific alternative splic-
ing events, the factors that control these events, and the effects they
have on specification and function of individual classes of neurons.
Although progress has been made toward understanding splic-
ing changes in the development of the nervous system, much less
is known about the interplay between alternative splicing regu-
lation and aging in the brain. It has been known for some time
that aberrant splicing of the LMNA gene leads to an accelerated
aging phenotype found in individuals with Hutchinson-Gilford
Progeria Syndrome (HGPS; Todorova et al., 2003). Recent studies
using patient cell lines and HGPS mouse models have identified
candidate regulators involved in the cryptic splicing of LMNA
(Lopez-Mejia et al., 2011). It is tempting to speculate that analy-
sis of the aging brain will also implicate splicing factors in both
aging-related splicing changes and the gradual deterioration of
the nervous system. Indeed, a recent study has identified dynamic
alterations in splicing during normal brain aging consistent with
an increase in PTB-dependent splicing, as well as splicing changes
in diseased brain consistent with decreased NOVA-dependent
splicing (Tollervey et al., 2011). In the future, it will be important to
more directly understand the mechanisms and the consequences
of splicing in the aging brain.
Finally, mutations in several RNA binding proteins expressed
in the nervous system have been associated with neurodevelop-
mental disorders (Grabowski and Black, 2001; Wang and Cooper,
2007; Morikawa and Manabe, 2010). Advances in genome-wide
approaches to globally monitor transcripts bound by these pro-
teins and their effects on aspects of mRNA metabolism, including
alternative splicing, are beginning to shed light on underlying
mechanisms of action and provide a more detailed understanding
of disease etiology. Deeper investigation of the transcript networks
regulated by these RNA binding proteins will hopefully provide
promising new insight into the development of treatments for
some of these disorders.
As demonstrated by some of the examples described above,
alternative splicing has the potential to generate multiple pro-
tein isoforms, but can also modulate other properties of mRNA
transcripts, including their stability. Two recent studies have sug-
gested that tissue-specific alternative exons can frequently encode
structurally disordered regions in proteins and have the potential
to influence post-translational modification and protein–protein
interaction interfaces (Buljan et al., 2012; Ellis et al., 2012). These
observations collectively indicate that it remains an important goal
to develop additional techniques and approaches that will facilitate
the characterization of the functional consequences of alternative
splicing events in biological pathways.
We are embarking on an exciting time where techniques for
large scale analysis of nervous system transcriptome dynamics in
distinct cellular subtypes, multiple developmental states, and in
response to environmental cues, are constantly improving. These
approaches are already revealing a previously unappreciated role
for post-transcriptional gene regulatory mechanisms in almost all
aspects of nervous system physiology. Continued research taking
advantage of these techniques, coupled with emerging computa-
tional approaches and more traditional biochemical and molecu-
lar genetic assays, will produce a more comprehensive understand-
ing of alternative splicing regulation. These integrative analyses
should also shed further light on the interplay between alterna-
tive splicing and other layers of gene regulation in generating the
constellation of neuronal subtypes and their diverse functional
properties.
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